These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30553788)

  • 1. Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors.
    Bledsoe D; Vacca B; Laube B; Klein BG; Costa B
    Eur J Pharmacol; 2019 Feb; 844():216-224. PubMed ID: 30553788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity.
    Bledsoe D; Tamer C; Mesic I; Madry C; Klein BG; Laube B; Costa BM
    Front Pharmacol; 2017; 8():229. PubMed ID: 28536523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
    Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
    Tajima N; Karakas E; Grant T; Simorowski N; Diaz-Avalos R; Grigorieff N; Furukawa H
    Nature; 2016 Jun; 534(7605):63-8. PubMed ID: 27135925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors.
    McClymont DW; Harris J; Mellor IR
    Eur J Pharmacol; 2012 Jul; 686(1-3):22-31. PubMed ID: 22564863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors.
    Hemelikova K; Kolcheva M; Skrenkova K; Kaniakova M; Horak M
    Neuropharmacology; 2019 Oct; 157():107671. PubMed ID: 31202607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.
    Kvist T; Steffensen TB; Greenwood JR; Mehrzad Tabrizi F; Hansen KB; Gajhede M; Pickering DS; Traynelis SF; Kastrup JS; Bräuner-Osborne H
    J Biol Chem; 2013 Nov; 288(46):33124-35. PubMed ID: 24072709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors.
    Mesic I; Madry C; Geider K; Bernhard M; Betz H; Laube B
    Neuropharmacology; 2016 Jun; 105():133-141. PubMed ID: 26777280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrangement of subunits in functional NMDA receptors.
    Salussolia CL; Prodromou ML; Borker P; Wollmuth LP
    J Neurosci; 2011 Aug; 31(31):11295-304. PubMed ID: 21813689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential contribution of GluN1 and GluN2 to the gating operation of the NMDA receptor channel.
    Tu YC; Kuo CC
    Pflugers Arch; 2015 Sep; 467(9):1899-917. PubMed ID: 25339225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
    Yi F; Traynelis SF; Hansen KB
    Methods Mol Biol; 2024; 2799():55-77. PubMed ID: 38727903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists.
    Rouzbeh N; Rau AR; Benton AJ; Yi F; Anderson CM; Johns MR; Jensen L; Lotti JS; Holley DC; Hansen KB
    J Gen Physiol; 2023 Jun; 155(6):. PubMed ID: 37078900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
    Yi F; Traynelis SF; Hansen KB
    Methods Mol Biol; 2017; 1677():145-162. PubMed ID: 28986871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
    Talukder I; Wollmuth LP
    J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.